As part of its Community Case Forum series, key opinion leaders and participants discuss the use of CAR T-cell therapy for the treatment of patients with multiple myeloma.
Advancing Multiple Myeloma Treatment With CAR T-Cell Therapy
Daniel Verina, DNP, ACNP-BC, discussed how CAR T-cell therapy is changing the treatment landscape for patients with multiple myeloma.
Managing Adverse Effects of CAR T-Cell Therapy in Multiple Myeloma
Donna Catamero, ANP-BC, OCN, CCRC, discusses the importance of quickly identifying and managing adverse effects from CAR T-cell therapy in patients with multiple myeloma.
Understanding the Mechanism of Action Behind PARP Inhibitors for Prostate Cancer
Tools to Monitor for ICANS During Lymphoma Treatment With Bispecific Antibodies, CAR T-Cell Therapy
‘Bringing Every Single Resource’ When Caring for Patients Receiving Treatment for Gynecologic Cancers
Bringing DEI to Clinical Trial, Cancer Clinics Through Self-Awareness